News in the Life Sciences Industry

STOCKHOLM, April 15, 2019 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its Annual Report for 2018 is now available on the company's website, Read more ››

STOCKHOLM, April 15, 2019 /PRNewswire/ -- The sector fund Rhenman Healthcare Equity L/S was named a winner at this year's Nordic Hedge Awards; best-performing Nordic hedge fund for five years. The award was made in the category "Performance Award for 60 Months".

LUND, Sweden, April 15, 2019 /PRNewswire/ -- Hansa Biopharma AB (NASDAQ Stockholm: HNSA), the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that its Annual Report for 2018 is now available on the company's website, Read more ››

LUND, Sweden, April 15, 2019 /PRNewswire/ -- Hansa Biopharma AB (NASDAQ Stockholm: HNSA), the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that it has divested its entire equity stake in Genovis AB (NASDAQ Stockholm: GENO). The transaction... Read more ››

LINKÖPING, Sweden and ODENSE, Denmark, April 15, 2019 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra... Read more ››

STOCKHOLM, April 15, 2019 /PRNewswire/ -- The shareholders in IRRAS AB (publ), reg. no. 556872-7134, are hereby invited to attend the annual general meeting ("AGM") to be held on Tuesday 14 May 2019 at 12.00 noon at IVA Konferenscenter, Grev Turegatan 16 in Stockholm, Sweden.

SUNDSVALL, Sweden, April 15, 2019 /PRNewswire/ -- Permobil, a global leader in advanced rehabilitation technology, has updated its successful modular front wheel drive chair with new functions for improved body support and comfort, more flexible body positioning and smoother driving, as well... Read more ››

STOCKHOLM, April 12, 2019 /PRNewswire/ -- Ortoma has signed an exclusivity agreement under a memorandum of understanding (MoU) with a European company that has Chinese ownership interests. With the MoU, Ortoma undertakes not to initiate discussions or negotiations with other companies with... Read more ››

STOCKHOLM, April 12, 2019 /PRNewswire/ --On 25 April, at 08:00 CET, Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) will... Read more ››

STOCKHOLM, April 11, 2019 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that 197 patients, of the total 215 planned, have been enrolled to date in the CONDUCT study evaluating the drug candidate cobitolimod. The patient recruitment has varied significantly on a monthly... Read more ››

UPPSALA, Sweden, April 11, 2019 /PRNewswire/ --

STOCKHOLM, April 11, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) today announced that it has updated its financial calendar, the interim report for Q2 2019 have been moved to 28 August.

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.

GETINGE, Sweden, April 10, 2019 /PRNewswire/ -- Getinge is today announcing clearance from the US Food & Drug Administration (FDA) for a new software version for the Servo-u® and Servo-n® mechanical ventilator platform. This software release includes the addition of Servo Compass®... Read more ››

UPPSALA, Sweden, April 10, 2019 /PRNewswire/ -- Biovica has agreed on a collaboration with IBL-America for sales of DiviTum® for the research market in the US. The partnership will further increase the commercial activities for this customer segment on the single largest market... Read more ››

LUND, Sweden, April 10, 2019 /PRNewswire/ -- Immunovia today announced that Prof. Stephen Pereira and his team at the institute for Liver and Digestive Health, University College London (UCL) will expand the prospective collection of blood samples funded by Immunovia and that started with the... Read more ››

STOCKHOLM, April 10, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) today announced that the US patent and trademark office has issued a notice that they intend to grant additional patents to Oncopeptides AB in the US. Oncopeptides has previously received the corresponding... Read more ››